Teaching EBLM: How to spread the word? Robert H. Christenson, Ph.D., DABCC, FACB Professor of Pathology Professor of Medical & Research Technology University of Maryland School of Medicine 1 Evidence-Based Medicine (EBM) Use of strongest available data to make informed, unbiased, decisions about the diagnosis and treatment of patients. (JAMA 1992:268;2420.) 2 Evidence-Based Medicine “……trying to improve the quality of the information on which decisions are based.” Glasziou et al 2003 3 Evidence-Based Medicine: Clinical versus Laboratory Clinical EBM Questions: Treatment and Intervention Versus Evidence Based Laboratory Medicine (EBLM) Questions: Information 4 Evidence-Based (Laboratory) Medicine Process Clinical or Policy Problems ASK ASSESS APPLY A5 Cycle ACQUIRE APPRAISE 5 ASK the Question Most Important Aspect Of EBM or EBLM 6 Types of Clinical Questions • Screen for disease • Rule-in diagnosis • Rule-out diagnosis • Assess prognosis • Start intervention or treatment • Adjust intervention or treatment • Stop intervention or treatment • Assess efficacy • Assess compliance 7 Formulate an Answerable Question the PICO system • Population/patient • Indicator/intervention/test • Comparator/control • Outcome • Setting • Timing 8 Formulate an Answerable Question B-type Natriuretic Peptide (BNP) in Urgent Care Can I use the plasma BNP test to rule-in or rule-out decompensated heart failure in patients presenting with dyspnea to urgent care? 9 Formulate an Answerable Question BNP in Urgent Care Can I use the plasma BNP test (I) to rule-in or rule-out (O) decompensated heart failure in patients presenting with dyspnea (P) to urgent care (S)? Comparison: gold standard diagnosis 10 ACQUIRE the Information 11 APPRAISE the Information 12 Quantitative Effects of Study Characteristics on Estimates of Diagnostic Accuracy Study Characteristic Relative Diagnostic Odds Ratio (95% Confidence Interval) Spectrum bias Differential verification Partial verification No blinding Selection bias Retrospective design Absence test description No population description No reference standard description Relative Diagnostic Odds Ratio (95% Confidence Interval) 13 Lijmer J. et al. JAMA 1999; 282:1061-1066 Spreading the Word • Teaching must be focused on learners’ needs. • Be prepared to discuss the context of EBLM. • Address any anxiety about acquiring the skills needed to use EBLM • Learning needs to be connected to how EBLM will be used in practice. • Learning needs to balance passive versus active methods. • Be alert for teachable moments. • Seek feedback and evaluation of your performance as a teacher. 14 Teaching must be focused on learners’ needs. Learning needs to be connected to how EBLM will be used in practice. 15 Expression for Bayes theorem is: Posttest odds = Pretest odds X likelihood ratio 16 Probability vs. Odds Probability: Likelihood 25 25 = 0.25 75 75 25 Odds: Odds Ratio 25 = 0.333 Humans are used To thinking in probabilities rather than odds 75 17 The Clinical Process History and physical exam Determines Pretest probability Guides Choice of Diagnostic studies Post Test Probability 18 Fagan’s Diagram 19 BNP in Urgent Care Plasma BNP is measured to rule-in or rule-out decompensated heart failure in 70 year-old dyspnea patient presenting to urgent care. BNP value is 125 ng/mL Does this patient have DHF? 20 ROC CURVE ANALYSIS N Engl J Med 2002;347:161-167. N = 1586 1.0 BNP = 50 (pg/ml) BNP = 80 (pg/ml) Sensitivity 0.8 BNP = 100 (pg/ml) BNP = 125 (pg/ml) BNP = 150 (pg/ml) 0.6 AUC = 0.91 (0.90-0.93) 0.4 0.2 0.0 0.0 0.2 0.4 0.6 0.8 1.0 21 1-Specificity Rapid measurement of BNP in the Emergency Diagnosis of Heart Failure Engl J Med 2002;347:161-167. N = 1586 Heart Failure 744 Not Heart Failure 770 72 Pretest probability = 50% History of LV Dysfunction 22 (Dyspnea due to Non-Cardiac Cause) ROC CURVE ANALYSIS N Engl J Med 2002;347:161-167. N = 1586 1.0 BNP = 50 (pg/ml) BNP = 80 (pg/ml) Sensitivity 0.8 BNP = 100 (pg/ml) BNP = 125 (pg/ml) BNP = 150 (pg/ml) 0.6 AUC = 0.91 (0.90-0.93) 0.4 Sensitivity 0.2 0.85 +LR = ------------------------ = --------- = (1 – Specificity) 0.22 3.9 0.0 0.0 0.2 0.4 0.6 1-Specificity 0.8 1.0 23 Fagan’s Diagram PostTest = 0.80 PreTest = 0.50 24 ROC CURVE ANALYSIS N Engl J Med 2002;347:161-167. N = 1586 If BNP=1000 1.0 BNP = 50 (pg/ml) BNP = 80 (pg/ml) Sensitivity 0.8 BNP = 100 (pg/ml) BNP = 125 (pg/ml) BNP = 150 (pg/ml) 0.6 AUC = 0.91 (0.90-0.93) 0.4 Sensitivity 0.2 0.60 +LR = ------------------------ = --------- = 12 (1 – Specificity) 0.05 0.0 0.0 0.2 0.4 0.6 1-Specificity 0.8 1.0 25 Fagan’s Diagram PostTest = 0.93 PreTest = 0.50 26 Probability of Diagnosis 0% Treatment Threshold Test Threshold 100% Probability below test threshold: no testing warranted Probability above treatment threshold; testing completed; treatment commences Probability between test and treatment threshold: further testing required 27 Who enrolled in the BNP Study? Pre-test likelihood of Disease No renal insufficiency (creatinine <1.5 mg/dL) 47% 28% 25% 28 McCullough et al. Circulation 2002;106:416 ROC Curves Lower by 15% in General Use 0.75 1.00 Moons KG, Donders AR, Steyerberg EW, Harrell FE. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. J Clin Epidemiol 2004;57(12):1262-70. Sensitivity 0.50 150 pg/mL 0.25 Sensitivity 0.75 0.00 +LR = ------------------------ = --------- = 2.0 (1 – Specificity) 0.35 0.00 0.25 0.50 1 - Specificity 0.75 1.00 ROC Curve Area =0.74 95% Confidence Interval = (0.69, 0.76) From: Clin Chem. 2007;53:1511-9. 29 Fagan’s Diagram PostTest = 0.64 PreTest = 0.50 30 BNP in Urgent Care Plasma BNP is measured to rule-in or rule-out decompensated heart failure in 70 year-old dyspnea patients presenting to urgent care. BNP value is 150 ng/mL Does this patient have DHF? 31 How to spread the word? • • • • • Teach to the needs of the students (audience). Project excitement about the topic Look for (or create) teachable moments. Use practical examples. Learning needs to balance passive versus active methods. It all starts with the clinical question (PICO). 32 Grazie Mille! 33
© Copyright 2024